LabConnect Expands North American Headquarters in Seattle
The success of LabConnect’s Scientific Operations Support (SciOps) team and overall company growth are behind its move to larger quarters in Seattle’s historic district.
“We needed to expand because we are growing,” said LabConnect President and Chief Executive Officer Eric Hayashi. “But beyond the additional space needed for our core office functions, we wanted to create just-in-time space for our growing SciOps team members who spend most of their time off site with clients. This move will give us room to double our capacity and allow us to better serve our clients.”
LabConnect provides central laboratory testing services to the biopharmaceutical industry through a global network of regional and local laboratories. The SciOps team is a special unit comprised of industry experts with a minimum of 10 years of experience who offer short- or long-term functional outsourcing services for pharmaceutical research.
“Our customers want to focus on getting the job done well, not on the human resources aspects,” Hayashi said. “We help with both. We provide experienced research professionals and take care of all the details such as payroll and benefits. Demand for this service has been strong since the beginning and it is still growing.”
LabConnect’s new headquarters is in Seattle’s historic Mutual Life Building at 605 First Ave., Ste. 300. Contact LabConnect at 206-322-4680 or by email at [email protected].
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
